IL-17 inhibitors - Novel Indications Save
Dr. Peter Nash offers perspectives on data presented about prospective novel indications for IL-17 inhibitors in the treatment of vasculitis, including giant cell arteritis and polymyalgia rheumatica, at EULAR 2025 meeting in Barcelona
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.